Gilteritinib: Repurposing of AXL‐targeting kinase inhibitors against COVID‐19
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28592
Abstract: The coronavirus disease‐19 (COVID‐19) is an ongoing infection outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel positive single‐stranded, enveloped RNA virus belonging to the genus Betacoronavirus. During the pandemic, the SARS‐CoV‐2… read more here.
Keywords: kinase inhibitors; axl targeting; repurposing axl; targeting kinase ... See more keywords